Table 2.

Tau-U effect sizes.

	Baseline phase vs. AT phase (non-treatment condition)			Baseline phase vs. AT phase (treatment condition)
	Tau-U	p	83.4% CI	Tau-U	p	83.4% CI
School A	− .24	.376	− .62–.15	1	<.001	.60–1.36
School B	.28	.301	− .11–.66	1	<.001	.60–1.36

Note. AT = alternating treatments.